Received: 16 January 2021
Accepted: 16 March 2021
First Online: 1 April 2021
: Informed consent was obtained from all individual participants included in the study.
: BCB received salary support from Boehringer-Ingelheim for a clinical research fellowship (11/2017–11/2018) and grant funding for an investigator-initiated study from the American Cancer Society (1/2020–12/2020). Both projects are unrelated to the current submission.FL received a consultant fee from IVIVA Inc. for an unrelated project.GG, LL, LT, GAS, and MLI have no financial disclosures.No authors have non-financial competing interests in this project.
: All procedures performed in studies involving were human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Yale Cancer Center’s Thoracic Oncology Disease Aligned Research Team (DART) and Yale University’s institutional review board/Human Investigations Committee (HIC# 2000022225). As a prospective intervention, the study was registered with ExternalRef removed (ExternalRef removed).
: Not applicable.